Terms: = Thyroid cancer AND TBX3, TBX3-ISO, ENSG00000135111, 6926, O15119, XHL, UMS
5 results:
1. tbx3 activating PVT1 accelerates proliferation, migration, and invasion by modulating the miR-30a/LOX axis in anaplastic thyroid carcinoma.
Wen J; Zhang W; Zhou Y; Hu X; Luo L; Zhou J; Shi L; Zhou S
Endokrynol Pol; 2022; 73(4):690-698. PubMed ID: 35971932
[TBL] [Abstract] [Full Text] [Related]
2. Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors.
Zhang P; Guan H; Yuan S; Cheng H; Zheng J; Zhang Z; Liu Y; Yu Y; Meng Z; Zheng X; Zhao L
Nat Commun; 2022 Mar; 13(1):1588. PubMed ID: 35332119
[TBL] [Abstract] [Full Text] [Related]
3. USP7 promotes proliferation of papillary thyroid carcinoma cells through tbx3-mediated p57
Xie P; Wang H; Xie J; Huang Z; Chen S; Cheng X; Zhang X; Liu F; Li Y; Huang D
Mol Cell Endocrinol; 2020 Dec; 518():111037. PubMed ID: 32966862
[TBL] [Abstract] [Full Text] [Related]
4. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.
Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
[TBL] [Abstract] [Full Text] [Related]
5. tbx3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
[TBL] [Abstract] [Full Text] [Related]
